Predictors of long-term cardiovascular outcomes in patients with type 2 diabetes mellitus

被引:0
|
作者
Bianco, H. [1 ]
Helfenstein, T. [1 ]
Izar, M. C. [1 ]
Fonseca, H. A. [1 ]
Fischer, S. C. [1 ]
Ferreira, C. E. [1 ]
Xavier, H. T.
Povoa, R. M. [1 ]
Fonseca, F. A. [1 ]
机构
[1] Fed Univ Sao Paulo UNIFESP, Dept Med, Sao Paulo, Brazil
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:893 / 893
页数:1
相关论文
共 50 条
  • [1] PATTERNS AND PREDICTORS OF LONG-TERM WEIGHT CHANGE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Janghorbani, Mohsen
    ANNALS OF NUTRITION AND METABOLISM, 2009, 55 : 405 - 405
  • [2] Patterns and Predictors of Long-Term Weight Change in Patients with Type 2 Diabetes Mellitus
    Janghorbani, Mohsen
    Amini, Masoud
    ANNALS OF NUTRITION AND METABOLISM, 2009, 54 (02) : 111 - 118
  • [3] Long-term insulin glargine therapy in type 2 diabetes mellitus: a focus on cardiovascular outcomes
    Joseph, Joshua J.
    Donner, Thomas W.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2015, 11 : 107 - 116
  • [4] Long-term maintenance of efficacy of dapagliflozin in patients with type 2 diabetes mellitus and cardiovascular disease
    Leiter, L. A.
    Cefalu, W. T.
    de Bruin, T. W. A.
    Xu, J.
    Parikh, S.
    Johnsson, E.
    Gause-Nilsson, I.
    DIABETES OBESITY & METABOLISM, 2016, 18 (08): : 766 - 774
  • [5] GlycA and Long-term Outcome in Patients with Type 2 Diabetes mellitus in Secondary cardiovascular Prevention
    Zierfuss, Bernhard
    Hoebaus, Clemens
    Herz, Carsten T.
    Pesau, Gerfried
    Mrak, Daniel
    Koppensteiner, Renate
    Schernthaner, Gerit-Holger
    WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (SUPPL 6) : 234 - 234
  • [6] Long-Term Outcomes of COVID-19 in Hospitalized Type 2 Diabetes Mellitus Patients
    Khamidullina, Zemfira
    Avzaletdinova, Diana
    Gareeva, Diana
    Morugova, Tatyana
    Lakman, Irina
    Kopp, Kristen
    Fiedler, Lukas
    Motloch, Lukas J.
    Zagidullin, Naufal
    BIOMEDICINES, 2024, 12 (02)
  • [7] Long-Term Outcomes of Analogue Insulin Compared With NPH for Patients With Type 2 Diabetes Mellitus
    Prentice, Julia C.
    Conlin, Paul R.
    Gellad, Walid F.
    Edelman, David
    Lee, Todd A.
    Pizer, Steven D.
    AMERICAN JOURNAL OF MANAGED CARE, 2015, 21 (03): : E235 - U78
  • [8] Predictors of long-term outcome following percutaneous coronary intervention in patients with type 2 diabetes mellitus
    Thanyasiri, Panuratn
    Celermajer, David S.
    Adams, Mark R.
    CORONARY ARTERY DISEASE, 2006, 17 (02) : 131 - 138
  • [9] Predictors of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus
    Tan, M. C.
    Wong, T. W.
    Chan, Y. M.
    Joseph, A.
    Hejar, A. R.
    Ng, O. C.
    INTERNATIONAL JOURNAL OF COLLABORATIVE RESEARCH ON INTERNAL MEDICINE & PUBLIC HEALTH, 2013, 5 (07) : 492 - 506
  • [10] Cardiovascular Biomarkers and Long-term Outcomes in Patients with Type 2 Diabetes Mellitus Treated with Alogiptin vs. Placebo in the EXAMINE Trial
    Morrow, David A.
    Cannon, Christopher P.
    Zannad, Faiz
    Cushman, William C.
    Bakris, George L.
    Nissen, Steven E.
    Heller, Simon R.
    Bergenstal, Richard M.
    Perez, Alfonso T.
    Fleck, Penny R.
    Mehta, Cyrus R.
    Kupfer, Stuart
    Lam, Hung
    Wilson, Craig
    White, William B.
    CIRCULATION, 2014, 130